{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:14:22Z","timestamp":1790367262741,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,15]]},"DOI":"10.7759\/cureus.77499","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T21:48:32Z","timestamp":1736977712000},"source":"Crossref","is-referenced-by-count":4,"title":["Indications for Blood Transfusion and Exchange Transfusion in Sickle Cell Disease: A Single Center Experience"],"prefix":"10.7759","author":[{"given":"Essa","family":"Alsharari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulelah","family":"Al Enazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab","family":"Hanafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadwa","family":"Abufara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M","family":"Altoonisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3109\/03630269.2011.596984","article-title":"Blood transfusion in sickle cell disease","volume":"35","author":"Marouf R","year":"2011","unstructured":"Marouf R. Blood transfusion in sickle cell disease. Hemoglobin. 2011, 35:495-502. 10.3109\/03630269.2011.596984","journal-title":"Hemoglobin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e328321882e","article-title":"Current issues in blood transfusion for sickle cell disease","volume":"21","author":"Wahl S","year":"2009","unstructured":"Wahl S, Quirolo KC. Current issues in blood transfusion for sickle cell disease. Curr Opin Pediatr. 2009, 21:15-21. 10.1097\/MOP.0b013e328321882e","journal-title":"Curr Opin Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009283","article-title":"Transfusion therapy for sickle cell disease: what's new?","volume":"7","author":"Chou ST","year":"2023","unstructured":"Chou ST, Hendrickson JE, Fasano RM. Transfusion therapy for sickle cell disease: what's new?. Blood Adv. 2023, 7:2551-3. 10.1182\/bloodadvances.2022009283","journal-title":"Blood Adv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2020.1767738","article-title":"Outcomes of a preoperative risk-based transfusion assignment protocol in sickle cell disease patients: a single-center retrospective study from Saudi Arabia","volume":"37","author":"Albolowi N","year":"2020","unstructured":"Albolowi N, Mustafa O, Almohammadi M, Al-Hindi MY, Jastaniah W. Outcomes of a preoperative risk-based transfusion assignment protocol in sickle cell disease patients: a single-center retrospective study from Saudi Arabia. Pediatr Hematol Oncol. 2020, 37:599-609. 10.1080\/08880018.2020.1767738","journal-title":"Pediatr Hematol Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-013-1163-z","article-title":"Transfusion in sickle cell disease: experience from a Gujarat centre","volume":"81","author":"Mehta V","year":"2014","unstructured":"Mehta V, Mistry A, Raicha B, Italia Y, Serjeant G. Transfusion in sickle cell disease: experience from a Gujarat centre. Indian J Pediatr. 2014, 81:234-37. 10.1007\/s12098-013-1163-z","journal-title":"Indian J Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2020.07.007","article-title":"Transfusion support in patients with sickle cell disease","volume":"57","author":"Sharma D","year":"2020","unstructured":"Sharma D, Ogbenna AA, Kassim A, Andrews J. Transfusion support in patients with sickle cell disease. Semin Hematol. 2020, 57:39-50. 10.1053\/j.seminhematol.2020.07.007","journal-title":"Semin Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2002.00396.x","article-title":"The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease","volume":"6","author":"Danielson CF","year":"2002","unstructured":"Danielson CF. The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher. 2002, 6:24-31. 10.1046\/j.1526-0968.2002.00396.x","journal-title":"Ther Apher"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2019.03.006","article-title":"Red blood cell exchange in children and adolescents with sickle cell disease","volume":"58","author":"Merlin E","year":"2019","unstructured":"Merlin E, Hequet O, Kanold J. Red blood cell exchange in children and adolescents with sickle cell disease. Transfus Apher Sci. 2019, 58:136-41. 10.1016\/j.transci.2019.03.006","journal-title":"Transfus Apher Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15188","article-title":"Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients","volume":"59","author":"Hequet O","year":"2019","unstructured":"Hequet O, Poutrel S, Connes P, et al.. Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients. Transfusion. 2019, 59:1692-97. 10.1111\/trf.15188","journal-title":"Transfusion"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13348","article-title":"Guideline on the management of acute chest syndrome in sickle cell disease","volume":"169","author":"Howard J","year":"2015","unstructured":"Howard J, Hart N, Roberts-Harewood M, Cummins M, Awogbade M, Davis B. Guideline on the management of acute chest syndrome in sickle cell disease. Br J Haematol. 2015, 169:492-505. 10.1111\/bjh.13348","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004395","article-title":"Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage","volume":"5","author":"Uter S","year":"2021","unstructured":"Uter S, An HH, Linder GE, et al.. Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage. Blood Adv. 2021, 5:2586-92. 10.1182\/bloodadvances.2021004395","journal-title":"Blood Adv"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2005.07.002","article-title":"Transfusion management in sickle cell disease","volume":"19","author":"Wanko SO","year":"2005","unstructured":"Wanko SO, Telen MJ. Transfusion management in sickle cell disease. Hematol Oncol Clin North Am. 2005, 19:803-26, v-vi. 10.1016\/j.hoc.2005.07.002","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2022.103556","article-title":"Transfusion support for patients with sickle cell disease","volume":"61","author":"Wallace LR","year":"2022","unstructured":"Wallace LR, Thibodeaux SR. Transfusion support for patients with sickle cell disease. Transfus Apher Sci. 2022, 61:103556. 10.1016\/j.transci.2022.103556","journal-title":"Transfus Apher Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16225","article-title":"Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion","volume":"61","author":"Ziemba Y","year":"2021","unstructured":"Ziemba Y, Xu C, Fomani KM, et al.. Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion. Transfusion. 2021, 61:526-36. 10.1111\/trf.16225","journal-title":"Transfusion"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The preoperative transfusion in sickle cell disease study group","volume":"333","author":"Vichinsky EP","year":"1995","unstructured":"Vichinsky EP, Haberkern CM, Neumayr L, et al.. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The preoperative transfusion in sickle cell disease study group. N Engl J Med. 1995, 333:206-13. 10.1056\/NEJM199507273330402","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard J","year":"2013","unstructured":"Howard J, Malfroy M, Llewelyn C, et al.. The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial. Lancet. 2013, 381:930-38. 10.1016\/S0140-6736(12)61726-7","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2018.07.003","article-title":"Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: a systematic review","volume":"33","author":"Fasano RM","year":"2019","unstructured":"Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR. Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: a systematic review. Transfus Med Rev. 2019, 33:12-23. 10.1016\/j.tmrv.2018.07.003","journal-title":"Transfus Med Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-021-03221-8","article-title":"Red blood cell exchange in children with sickle cell disease","volume":"115","author":"Elenga N","year":"2022","unstructured":"Elenga N, Vantilcke V, Martin E, Cuadro E, Selles P, Basset T. Red blood cell exchange in children with sickle cell disease. Int J Hematol. 2022, 115:107-13. 10.1007\/s12185-021-03221-8","journal-title":"Int J Hematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003146.pub3","article-title":"Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease","volume":"1","author":"Estcourt LJ","year":"2017","unstructured":"Estcourt LJ, Fortin PM, Hopewell S, Trivella M, Wang WC. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. Cochrane Database Syst Rev. 2017, 1:CD003146. 10.1002\/14651858.CD003146.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.ijmr_3447_21","article-title":"A systematic review on hydroxyurea therapy for sickle cell disease in India","volume":"156","author":"Pandey A","year":"2022","unstructured":"Pandey A, Kaur H, Borah S, et al.. A systematic review on hydroxyurea therapy for sickle cell disease in India. Indian J Med Res. 2022, 156:299-311. 10.4103\/ijmr.ijmr_3447_21","journal-title":"Indian J Med Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2475","article-title":"Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease","volume":"103","author":"Zimmerman SA","year":"2004","unstructured":"Zimmerman SA, Schultz WH, Davis JS, Pickens CV, Mortier NA, Howard TA, Ware RE. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood. 2004, 103:2039-45. 10.1182\/blood-2003-07-2475","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39384","article-title":"ChatGPT-4 and the global burden of disease study: advancing personalized healthcare through artificial intelligence in clinical and translational medicine","volume":"15","author":"Temsah MH","year":"2023","unstructured":"Temsah MH, Jamal A, Aljamaan F, Al-Tawfiq JA, Al-Eyadhy A. ChatGPT-4 and the global burden of disease study: advancing personalized healthcare through artificial intelligence in clinical and translational medicine. Cureus. 2023, 15:e39384. 10.7759\/cureus.39384","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/326088-indications-for-blood-transfusion-and-exchange-transfusion-in-sickle-cell-disease-a-single-center-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T21:48:34Z","timestamp":1736977714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/326088-indications-for-blood-transfusion-and-exchange-transfusion-in-sickle-cell-disease-a-single-center-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.77499","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,15]]}}}